Pharma white papers on contemporary issues, technologies, research, etc. are presented in this section to enable the readers with rich information and knowledge. This section provides white papers related to all the spheres of the pharma industry.

Driving value creation through medical affairs in China

After more than three decades of fast economic growth China has entered the new normal stage marked by a moderate and stable domestic GDP growth rate Healthcare has been elevated to a national level agenda by the current leadership with the releasing of China Health

Launching Global Clinical Trials—best Practices For Efficient And Cost-effective Translations: A Lionsbridge White Paper

Summary The target market for conducting global clinical trials has changed significantly moving beyond pharmaceutical early adopters to the mainstream marketplace This shift has placed a heightened focus on the language challenges and complexity of running a global clinical trial More and more companies are moving toward

Pharmacopeia Requirements For Pure Steam And Final Rinse Verification Of Cip: A METTLER TOLEDO White Paper

Summary Validation of Pure Steam and the verification of the final aqueous rinse in a CIP process are defined by regulatory standards which change periodically and challenge system designers and owners to know the latest requirements This white paper contains an overview of current pharmacopeia requirements which will assist in the design and monitoring of comp

Effective Randomization Is Key To The Success Of A Trial: A Cenduit White Paper

Summary Randomized doubleblind clinical trials are the gold standard for adequate and wellcontrolled studies in modern times However prior to the late s randomization and blinding were not used in medicine and as result bias was common For example treatment bias was often observed as physicians would treat sicker patients with known controls while

Improving Strategic Supplier Discovery Through Technology: A Procurepharma White Paper

Summary This white paper will explore current trends related to procurement and sourcing is evolving role in the supplier discovery process and current practices for accessing supplier information It will explore the ability of new technology to enable procurement and sourcing professionals to reduce the time spent identifying qualified suppliers prior to initiating the RFP process Finally

Meeting Current and Future Serialisation Challenges: An AESICA White Paper

Summary Serialisation has emerged as a complex challenge for the pharmaceuticals sector which is facing a multiplicity of differing regulations that vary from one country to another Several countries including China South Korea Turkey Argentina and Brazil already have regulations in place that must be complied with whilst many others including countries i

The Real Cost of Poor Data Integrity in Pharmaceutical Manufacturing: A Lachman White Paper

Summary Every business faces risk Broadly speaking the primary categories of business risk are Market Financial Execution and Regulatory Successful companies have developed a core competency in managing for these risks turning risk management into a sustainable competitive advantage For drug manufacturers recent trends have underscored the importance o

Indication-Specific Pricing Of Pharmaceuticals In The United States Health Care System: An ICER White Paper

Summary The Institute for Clinical and Economic Review ICER held a Policy Summit on December with health care leaders from the payer and life sciences organizations that comprise the ICER membership group The purpose of the meeting was to explore the potential value of indicationspecific pricing ISP of pharmaceuticals for both pay

How to Choose the Right Contract Manufacturing Organisation for Your Pharmaceutical Product: A Burrard Pharmaceuticals White Paper

Summary Contract manufacturing can enhance the drug development process by creating effective processes increasing manufacturing efficiencies and reducing overhead costs Selecting a CMO with two essential characteristics capability and partnershipchemistry is often difficult and challenging This white paper contains an allinclusive tenstep guide for s

Getting Serious About Serialization—A Comprehensive Look At The Legislation Shaping U.S. Pharmaceutical Supply Chains: An MD Logistics White Paper

Summary The World Health Organization WHO defines a counterfeit medication as a medication that is deliberately and fraudulently mislabelled with respect to identity andor source According to WHO counterfeiting can apply to both branded and generic products and can include products with the correct ingredients without active ingredients or with fake packaging

Latest Issue
Get instant
access to our latest e-book
Rousselot - X-Pure® || Modified Products The Live-to-Virtual Pivot 4 Best Practices Meco - 90 years Medical Fair Thailand 2022